Teriparatide contains not less than 95.0% and not more than 105.0% of C181H291N55O51S2, calculated on the anhydrous, acetic-free, and chloride-free basis.

共有 1 個藥物證書使用此成份

"霖揚"重組人類副甲狀腺素
Teriparatide "GBC"

• 申請商: 霖揚生技製藥股份有限公司
• 適應症: 副甲狀腺激素補充劑。
• 發證日期: 2022-12-23